Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiroaki Ono
Hiroaki Ono
Otsuka Pharmaceutical
Psychiatry
Psychology
Aripiprazole
Adverse effect
Placebo
4
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open‐label extension long‐term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan
2018
Psychiatry and Clinical Neurosciences
Hironobu Ichikawa
Michio Hiratani
Akihiro Yasuhara
Noa Tsujii
Takashi Oshimo
Hiroaki Ono
Yoshihiro Tadori
Show All
Source
Cite
Save
Citations (12)
Safety and efficacy from a 6-week double-blind study and a 52-week open-label extension of aripiprazole in adolescents with schizophrenia in Japan: Aripiprazole for schizophrenia
2018
Psychiatry and Clinical Neurosciences
Hideo Matsumoto
Jun Ishigooka
Hiroaki Ono
Yoshihiro Tadori
Show All
Source
Cite
Save
Citations (3)
Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study
2017
Child Psychiatry & Human Development
Hironobu Ichikawa
Katsunaka Mikami
Takashi Okada
Yushiro Yamashita
Yuko Ishizaki
Akemi Tomoda
Hiroaki Ono
Chiharu Usuki
Yoshihiro Tadori
Show All
Source
Cite
Save
Citations (35)
Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery–Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study
2015
Psychiatry and Clinical Neurosciences
Norio Ozaki
Tempei Otsubo
Masaki Kato
Teruhiko Higuchi
Hiroaki Ono
Kunitoshi Kamijima
Show All
Source
Cite
Save
Citations (20)
1